We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
(-3.3%)
Cap. Flow
+$3.24B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.25B |
| 2 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$938M |
| 3 |
Apple
AAPL
|
+$911M |
| 4 |
Costco
COST
|
+$878M |
| 5 |
NVIDIA
NVDA
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.69B |
| 2 |
ServiceNow
NOW
|
+$651M |
| 3 |
Applied Materials
AMAT
|
+$563M |
| 4 |
Visa
V
|
+$536M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$523M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Financials | 11.41% |
| 3 | Consumer Discretionary | 10.18% |
| 4 | Industrials | 9.65% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Vanguard Small-Cap ETF
VB
$79.5B
| $23.9M | 0.01% |
91,205
+10,125
| +12% | +$2.74M |
|
1027
Vanguard Russell 2000 ETF
VTWO
$17.3B
| $23.9M | 0.01% |
238,272
+22,592
| +10% | +$2.36M |
|
1028
First Citizens BancShares
FCNCA
$24.6B
| $23.8M | 0.01% |
12,647
+192
| +2% | +$385K |
|
1029
Extreme Networks
EXTR
$3.86B
| $23.8M | 0.01% |
1,576,509
-328,638
| -17% | -$4.9M |
|
1030
Element Solutions
ESI
$9.12B
| $23.7M | 0.01% |
693,889
+25,925
| +4% | +$812K |
|
1031
Conagra Brands
CAG
$7.07B
| $23.7M | 0.01% |
1,505,787
+401,470
| +36% | +$7.09M |
|
1032
Norwegian Cruise Line
NCLH
$8.89B
| $23.7M | 0.01% |
1,265,755
+46,387
| +4% | +$1.01M |
|
1033
Invesco QQQ Trust
QQQ
$455B
| $23.7M | 0.01% |
41,200
+200
| +0.5% | +$122K |
|
1034
SiteOne Landscape Supply
SITE
$4.43B
| $23.7M | 0.01% |
177,769
+92,486
| +108% | +$13.1M |
|
1035
ArcBest
ARCB
$3.44B
| $23.5M | 0.01% |
239,366
-119,983
| -33% | -$11.4M |
|
1036
Bio-Techne
TECH
$11.2B
| $23.5M | 0.01% |
450,286
-201,228
| -31% | -$12.1M |
|
1037
Annexon
ANNX
$855M
| $23.5M | 0.01% |
4,246,330
+1,331,006
| +46% | +$7.49M |
|
1038
Imperial Oil
IMO
$62.1B
| $23.5M | 0.01% |
179,742
-5,751
| -3% | -$645K |
|
1039
WisdomTree
WT
$2.97B
| $23.2M | 0.01% |
1,596,382
-162,747
| -9% | -$2.52M |
|
1040
Praxis Precision Medicines
PRAX
$9.07B
| $23.2M | 0.01% |
72,043
+22,073
| +44% | +$6.83M |
|
1041
Encore Capital Group
ECPG
$1.93B
| $23.2M | 0.01% |
330,948
+90,204
| +37% | +$5.54M |
|
1042
Cytokinetics
CYTK
$11B
| $23.2M | 0.01% |
351,809
-17,470
| -5% | -$1.11M |
|
1043
Charles River Laboratories
CRL
$10.9B
| $23.1M | 0.01% |
133,983
+7,163
| +6% | +$1.33M |
|
|
ECG
1044
Everus Construction Group
ECG
$6.63B
| $23.1M | 0.01% |
195,553
-3,329
| -2% | -$344K |
|
1045
Acadia Pharmaceuticals
ACAD
$4.25B
| $23.1M | 0.01% |
1,036,987
-20,540
| -2% | -$491K |
|
|
BORR
1046
Borr Drilling
BORR
$1.31B
| $22.9M | 0.01% |
3,975,871
+3,237,190
| +438% | +$16.6M |
|
|
OKLO
1047
Oklo
OKLO
$7B
| $22.9M | 0.01% |
461,143
+121,734
| +36% | +$8.75M |
|
1048
National Grid
NGG
$81.9B
| $22.8M | 0.01% |
269,843
+73,526
| +37% | +$6.33M |
|
1049
Brinker International
EAT
$8.02B
| $22.8M | 0.01% |
159,683
-31,113
| -16% | -$4.74M |
|
1050
Lithia Motors
LAD
$7.78B
| $22.8M | 0.01% |
91,113
-7,891
| -8% | -$2.34M |
|
Similar funds
VFT
Nuveen's Q1 2026 Portfolio in Review
As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
- Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
- Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
- Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
- Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
- Nuveen opened 48 new positions and closed 76 in Q1 2026.
- Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.